Results 101 to 110 of about 23,326 (221)

Two phase 3 trials of Dupilumab versus placebo in atopic dermatitis [PDF]

, 2017
Dahdah, Lamia, Fiocchi, Alessandro, Mennini, Maurizio   +2 more
core   +1 more source

Consistency of Response to Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis Over 1 Year [PDF]

, 2022
Andrew Blauvelt, Marjolein de Bruin‐Weller, Eric L. Simpson, Zhen Chen, Marius Ardeleanu, Ana B. Rossi   +5 more
openalex   +1 more source

Long-term outcomes of dupilumab therapy in severe asthma: A retrospective, multicenter, real-world study

Journal of Allergy and Clinical Immunology: Global
Background: Dupilumab is an IL-4Rα antibody approved for treatment of severe asthma. Real-world data on the continuation and cessation patterns of dupilumab and long-term treatment efficacy are scarce.
Carlo Mümmler, MD, Alexandra Lenoir, MD, Jeremias Götschke, MD, Michael Gerckens, MD, Merle Kaiser, MD, Moritz Kayser, MD, Nora Drick, MD, Hendrik Suhling, MD, Leonie Biener, MD, Carmen Pizarro, MD, Dirk Skowasch, MD, Nikolaus Kneidinger, MD, PhD, Jürgen Behr, MD, Katrin Milger, MD   +13 more
doaj   +1 more source

Preclinical and clinical experience with dupilumab on the correlates of live attenuated vaccines

, 2021
Michael E. Wechsler, Adelmir Souza‐Machado, Christine Xu, Xuezhou Mao, Upender Kapoor, Faisal A. Khokhar, John T. O’Malley, Christopher D. Petro, Veronica Mas Casullo, Leda Mannent, Paul J. Rowe, Juby A. Jacob‐Nara, Marcella Ruddy, Elizabeth Laws, Lisa A. Purcell, Megan Hardin   +15 more
openalex   +1 more source

Long-term efficacy and safety of dupilumab for severe bullous pemphigoid: A prospective cohort study

, 2023
Dawei Huang, Yuexin Zhang, Yingyuan Yu, Yuxiong Jiang, Luyang Kong, Yangfeng Ding, Yuling Shi, Yunlu Gao   +7 more
openalex   +1 more source

Adverse effects of dupilumab in a child with atopic dermatitis: A case report of anaphylaxis and literature review

Allergy Medicine
Atopic dermatitis (AD) is one of the most common chronic inflammatory skin diseases. It usually develops in childhood and may persist into adulthood. Dupilumab is a fully human monoclonal antibody directed against interleukin-4R-alpha, the common chain ...
Jing Zhang, Zhouxian Pan, Shisu Zhao, Jihan li, Jinlyu Sun   +4 more
doaj   +1 more source

Dupilumab versus Lebrikizumab Demonstrates Greater Likelihood of Achieving and Maintaining Improvements in Efficacy Outcomes Using a Placebo-Adjusted Indirect Treatment Comparison

Dermatology and Therapy
Introduction Dupilumab and lebrikizumab have demonstrated efficacy in atopic dermatitis (AD) clinical trials; however, no direct comparisons exist. Methods Efficacy outcome achievement (dupilumab and lebrikizumab with topical corticosteroids [TCS]) at 16 
Sonja Ständer, Andreas Pinter, Firas G. Hougeir, Patricia Guyot, Yingxin Xu, Amy H. Praestgaard, Nick Freemantle, Ana B. Rossi, Gaëlle Bégo-Le-Bagousse, Zhixiao Wang, Kerry Noonan, Mike Bastian   +11 more
doaj   +1 more source

Anaphylaxis Associated With Allergen Specific Immunotherapy, Omalizumab, and Dupilumab: A Real World Study Based on the US Food and Drug Administration Adverse Event Reporting System [PDF]

, 2021
Sainan Bian, Ping Zhang, Lisha Li, Zixi Wang, Le Cui, Yingyang Xu, Kai Guan, Bin Zhao, Zhuang‐Gui Chen   +8 more
openalex   +1 more source

Pronóstico y evolución de la rinosinusitis crónica poliposa intervenida mediante cirugía endoscópica nasosinusal según fenotipos y endotipos [PDF]

, 2019
Se realiza un estudio observacional de seguimiento desarrollado en el Hospital Clínico Universitario de Valladolid. La muestra consta de 20 pacientes intervenidos de rinosinusitis crónica poliposa mediante cirugía endoscópica nasosinusal (CENS) entre ...
Rivas González, Juan
core  

Dupilumab-Related Diabetes Mellitus With Reversal of Symptoms in a Non-genetically Predisposed Patient [PDF]

Tanner C Blaylock, Daniel Leon
openalex   +1 more source